The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shendelman Shoshana since 2019.
This trader's CIK number is 1775490.
At the time of last reporting, Shendelman Shoshana was the President and CEO of Applied Therapeutics, Inc.. (stock ticker symbol APLT).
Also see all insider trading activities at Applied Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | APLT | 0 | $0 | 1,157,382 | $6,696,110 | 0 | $0 |
| 2023 | APLT | 0 | $0 | 119,600 | $320,022 | 0 | $0 |
| 2022 | APLT | 161,409 | $93,080 | 0 | $0 | 0 | $0 |
| 2021 | APLT | 10,001 | $145,035 | 0 | $0 | 0 | $0 |
| 2020 | APLT | 0 | $0 | 215,000 | $7,994,570 | 215,000 | $282,100 |
| 2019 | APLT | 125,000 | $1,250,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-12 | APLT | Sale | 300,000 | 5.98 | 1,794,000 |
| 2024-08-13 | APLT | Sale | 357,423 | 6.18 | 2,208,874 |
| 2024-08-14 | APLT | Sale | 119,591 | 5.93 | 709,174 |
| 2024-06-06 | APLT | Sale | 61,795 | 4.32 | 266,954 |
| 2024-03-14 | APLT | Sale | 318,573 | 5.39 | 1,717,108 |
| 2023-11-30 | APLT | Sale | 3,968 | 1.97 | 7,816 |
| 2023-09-27 | APLT | Sale | 115,632 | 2.70 | 312,206 |
| 2022-10-14 | APLT | Buy | 50,000 | .65 | 32,250 |
| 2022-10-13 | APLT | Buy | 73,256 | .56 | 40,876 |
| 2022-10-12 | APLT | Buy | 38,153 | .52 | 19,954 |
| 2021-09-13 | APLT | Buy | 701 | 14.69 | 10,297 |
| 2021-09-14 | APLT | Buy | 9,300 | 14.49 | 134,738 |
| 2020-07-21 | APLT | Option Ex | 15,000 | 1.44 | 21,600 |
| 2020-07-20 | APLT | Sale | 15,000 | 27.90 | 418,545 |
| 2020-07-22 | APLT | Option Ex | 15,000 | 1.44 | 21,600 |
| 2020-07-21 | APLT | Sale | 15,000 | 27.45 | 411,750 |
| 2020-07-22 | APLT | Sale | 15,000 | 25.98 | 389,700 |
| 2020-07-20 | APLT | Option Ex | 15,000 | 1.44 | 21,600 |
| 2020-07-07 | APLT | Option Ex | 15,000 | 1.44 | 21,600 |
| 2020-07-09 | APLT | Sale | 15,000 | 31.27 | 469,050 |
| 2020-07-08 | APLT | Sale | 15,000 | 32.59 | 488,925 |
| 2020-07-09 | APLT | Option Ex | 15,000 | 1.44 | 21,600 |
| 2020-07-07 | APLT | Sale | 15,000 | 31.94 | 479,100 |
| 2020-07-08 | APLT | Option Ex | 15,000 | 1.44 | 21,600 |
| 2020-05-28 | APLT | Option Ex | 125,000 | 1.22 | 152,500 |
| 2020-05-28 | APLT | Sale | 125,000 | 42.70 | 5,337,500 |
| 2019-05-16 | APLT | Buy | 125,000 | 10.00 | 1,250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shendelman Shoshana (President and CEO of Applied Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.